GlassScriptPhysician profile
Rex Ghassemi
NPI 1942388921
$4,446.63
in general payments reported to CMS, 2019-2025
25 companies · $77.77 in 2025
The $77.77 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,612 · 2020: $341 · 2021: $332 · 2022: $1,002 · 2023: $518 · 2024: $565 · 2025: $77.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $432.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,243.07 | 2019-2022 | |
| Medtronic Vascular, INC. | $1,163.83 | 2019 | |
| Medtronic, INC. | $488.51 | 2021-2023 | Silverhawk, Turbohawk, Chocolate Pta Balloon Catheter |
| Abbvie INC. | $459.42 | 2023-2024 | |
| Allergan, INC. | $277.78 | 2019-2023 | |
| Revance Therapeutics, INC. | $149.22 | 2024 | Daxxify |
| Boston Scientific Corporation | $77.02 | 2022-2023 | Varithena Administration Pack |
| Cvrx, INC. | $70.00 | 2024-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $58.48 | 2022 | |
| Abbott Laboratories | $58.44 | 2019-2025 | Mitraclip |
| Amarin Pharma, INC. | $43.39 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $41.68 | 2019-2020 | |
| Irhythm Technologies, INC. | $39.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $36.70 | 2024-2025 | |
| Impulse Dynamics (USA) INC. | $34.44 | 2022-2023 | Optimizer |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $32.16 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Amgen INC. | $28.62 | 2024-2025 | Repatha, Repatha |
| Lundbeck LLC | $26.79 | 2021 | |
| Tactile Systems Technology INC | $19.96 | 2024 | Flexitouch Plus, Entre Plus |
| Cardiovascular Systems INC. | $18.84 | 2020 | |
| Biocompatibles, INC. | $17.96 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $16.37 | 2023 | Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.82 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.97 | 2021 | |
| Merck Sharp & Dohme LLC | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Ghassemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.